NO20001847L - Ny anvendelse av forbindelser for anti-kløe-aktivitet - Google Patents

Ny anvendelse av forbindelser for anti-kløe-aktivitet

Info

Publication number
NO20001847L
NO20001847L NO20001847A NO20001847A NO20001847L NO 20001847 L NO20001847 L NO 20001847L NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 L NO20001847 L NO 20001847L
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001847D0 (no
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847D0 publication Critical patent/NO20001847D0/no
Publication of NO20001847L publication Critical patent/NO20001847L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001847A 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet NO20001847L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847D0 NO20001847D0 (no) 2000-04-10
NO20001847L true NO20001847L (no) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847L (no) 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet

Country Status (18)

Country Link
EP (1) EP1030666A4 (tr)
JP (1) JP2001520196A (tr)
KR (1) KR20010031149A (tr)
CN (1) CN1306426A (tr)
AR (1) AR015966A1 (tr)
AU (1) AU740875B2 (tr)
BR (1) BR9814080A (tr)
CA (1) CA2306985A1 (tr)
CO (1) CO4810374A1 (tr)
CZ (1) CZ20001376A3 (tr)
HU (1) HUP0003792A3 (tr)
IL (1) IL135581A0 (tr)
NO (1) NO20001847L (tr)
NZ (1) NZ503551A (tr)
PL (1) PL341062A1 (tr)
TR (1) TR200001040T2 (tr)
WO (1) WO1999020280A1 (tr)
ZA (1) ZA989450B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248231T3 (es) 2001-01-31 2006-03-16 Pfizer Products Inc. Derivados de eteres utiles como inhibidores de las isozimas pde4.
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CN1489588A (zh) 2001-01-31 2004-04-14 �Ʒ� 用作pde4同功酶抑制剂的噻唑基,噁唑基,吡咯基,和咪唑基羧酸酰胺衍生物
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060258703A1 (en) * 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
PL1781657T3 (pl) 2004-02-14 2013-08-30 Glaxosmithkline Ip Dev Ltd Leki o aktywności wobec receptora HM74A
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
ES2401128T3 (es) 2005-08-10 2013-04-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de HM74A
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2007218725B2 (en) * 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
CA2696793A1 (en) 2007-08-17 2009-02-26 Eisai R&D Management Co., Ltd. Novel preparation for external use
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
ES2659458T3 (es) * 2011-06-28 2018-03-15 Mitsubishi Tanabe Pharma Corporation Compuestos de naftaleno para tratar el prurito
EP3251675B1 (en) 2015-01-30 2021-04-21 Shanton Pharma Pte. Ltd. Prevention or treatment of uric acid or gout disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (es) * 1990-12-21 2000-10-16 Beecham Group Plc Derivados de xantina.
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
ES2187775T3 (es) * 1996-05-15 2003-06-16 Altana Pharma Ag Imidazopiridinas.
SI0968211T1 (en) * 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
ES2193539T3 (es) * 1997-06-03 2003-11-01 Altana Pharma Ag Benzonaftiridinas.

Also Published As

Publication number Publication date
HUP0003792A2 (hu) 2001-10-28
CN1306426A (zh) 2001-08-01
EP1030666A1 (en) 2000-08-30
NO20001847D0 (no) 2000-04-10
CO4810374A1 (es) 1999-06-30
CA2306985A1 (en) 1999-04-29
ZA989450B (en) 1999-04-19
EP1030666A4 (en) 2002-10-16
JP2001520196A (ja) 2001-10-30
IL135581A0 (en) 2001-05-20
WO1999020280A1 (en) 1999-04-29
KR20010031149A (ko) 2001-04-16
TR200001040T2 (tr) 2001-01-22
BR9814080A (pt) 2000-09-26
AU1093899A (en) 1999-05-10
CZ20001376A3 (cs) 2002-06-12
HUP0003792A3 (en) 2001-12-28
AU740875B2 (en) 2001-11-15
NZ503551A (en) 2002-05-31
AR015966A1 (es) 2001-05-30
PL341062A1 (en) 2001-03-26

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
IS5354A (is) Ný efnasambönd
PT996622E (pt) Novos compostos heterociclicos espiroazabiciclicos
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
NO20015855D0 (no) Ny anvendelse av forbindelser som antibakterielle midler
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID22878A (id) Komposisi aktif secara terapi
NO993298D0 (no) Ny fremgangsmÕte
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24677A (id) Kombinasi senyawa aktif fungisidal
NO995796L (no) Ny fremgangsmåte
FI963531A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
FI963532A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
ID24694A (id) Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
NO963764D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
NO963762D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
SE9704838D0 (sv) New compounds
SE9702746D0 (sv) New compounds
SE9702378D0 (sv) New compounds
SE9702747D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application